XBP1 and colorectal carcinoma: Moreover, the IRE1α/XBP1 pathway inhibitor 4μ8C and glycolysis inhibitor 2-DG significantly suppress MC-LR-induced polarization of M2 macrophage and the malignant progression of CRC cells.